Plexiform neurolymphomatosis.
Department of Neurology, CHR Sambre & Meuse, avenue Albert Ier 185, 5000 Namur, Belgium. Electronic address: roger.denays@chrnamur.be.
R
R
Denays
Department of Radiology, CHR Sambre & Meuse, avenue Albert Ier 185, 5000 Namur, Belgium.
V
V
Baudrez
Department of Nuclear Medicine, CHR Sambre & Meuse, avenue Albert Ier 185, 5000 Namur, Belgium.
P
P
Abouhamad
Department of Nuclear Medicine, CHR Sambre & Meuse, avenue Albert Ier 185, 5000 Namur, Belgium.
T
T
Derème
Department of Neurosurgery, CHR Sambre & Meuse, avenue Albert Ier 185, 5000 Namur, Belgium.
G
G
Milbouw
Department of Hemato-Oncology, CHR Sambre & Meuse, avenue Albert Ier 185, 5000 Namur, Belgium.
J-P
JP
Hermanne
D000368:Aged; D000818:Animals; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D017254:Leukemic Infiltration / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology*; D016393:Lymphoma, B-Cell / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology*; D020361:Paraneoplastic Syndromes, Nervous System / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology*; D000072078:Positron Emission Tomography Computed Tomography; D011241:Prednisone / Q000627:therapeutic use; D000069283:Rituximab; D014750:Vincristine / Q000627:therapeutic use
D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D019788:Fluorodeoxyglucose F18; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone